U.S. markets open in 45 minutes

Sierra Oncology, Inc. (SRRA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.16-0.19 (-1.54%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/16/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
126.20M125.79M102.09M25.57M29.17M
Enterprise Value 3
3.42M-7.27M-45.07M-36.51M-44.05M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
1.080.971.180.430.41
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-0.050.442.801.463.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.33
52-Week Change 3-97.41%
S&P500 52-Week Change 314.13%
52 Week High 3880.00
52 Week Low 38.55
50-Day Moving Average 311.29
200-Day Moving Average 312.16

Share Statistics

Avg Vol (3 month) 323k
Avg Vol (10 day) 38.61k
Shares Outstanding 510.4M
Float 2.69M
% Held by Insiders 13.42%
% Held by Institutions 157.14%
Shares Short (Sep 29, 2020) 49.53k
Short Ratio (Sep 29, 2020) 40.68
Short % of Float (Sep 29, 2020) 40.30%
Short % of Shares Outstanding (Sep 29, 2020) 40.09%
Shares Short (prior month Aug 30, 2020) 46.59k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Jan 22, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-40.26%
Return on Equity (ttm)-116.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -67.6M
Net Income Avi to Common (ttm)-108.74M
Diluted EPS (ttm)-15.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)123.23M
Total Cash Per Share (mrq)11.85
Total Debt (mrq)446k
Total Debt/Equity (mrq)0.38
Current Ratio (mrq)13.88
Book Value Per Share (mrq)11.22

Cash Flow Statement

Operating Cash Flow (ttm)-47.79M
Levered Free Cash Flow (ttm)-31.56M